Jefferies Drops Price Target After ResMed (RMD) Heart Failure Trial Fails
Go back to Jefferies Drops Price Target After ResMed (RMD) Heart Failure Trial Fails| RESMED, Inc. (NYSE: RMD) | Delayed: 230.65 +10.67 (4.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.98 | 52 Week High | $70.90 | |||
| Open | $221.00 | 52 Week Low | $50.77 | |||
| Day High | $231.04 | P/E | 103.43 | |||
| Day Low | $220.44 | EPS | $2.23 | |||
| Volume | 1,209,807 | |||||

